North America Pharmaceutical Robots Market Size & Outlook
North America pharmaceutical robots market, 2016-2030 (US$M)
Related Markets
North America pharmaceutical robots market highlights
- The North America pharmaceutical robots market generated a revenue of USD 20.5 million in 2023.
- The market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
- In terms of segment, traditional robots was the largest revenue generating type in 2023.
- Collaborative Robots is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 20.5 million |
| Market revenue in 2030 | USD 43.2 million |
| Growth rate | 11.2% (CAGR from 2023 to 2030) |
| Largest segment | Traditional robots |
| Fastest growing segment | Collaborative Robots |
| Historical data covered | 2016 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Traditional Robots, Collaborative Robots |
| Key market players worldwide | ABB Ltd, Teradyne Inc, Kawasaki Heavy Industries Ltd, YASKAWA Electric Corp, Fanuc Corp, Marchesini Group, Seiko Epson Corp, Denso Corp, Mitsubishi Electric Corp, KUKA Robotics |
Other key industry trends
- In terms of revenue, North America region accounted for 10.3% of the global pharmaceutical robots market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 43.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Robots Market Scope
Pharmaceutical Robots Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America pharmaceutical robots market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical robots market will help companies and investors design strategic landscapes.
Traditional robots was the largest segment with a revenue share of 63.41% in 2023. Horizon Databook has segmented the North America pharmaceutical robots market based on traditional robots, collaborative robots covering the revenue growth of each sub-segment from 2016 to 2030.
North America held a significant share of 19.50% in 2020. This can be attributed to the largest number of robot installations in the region. According to IFR, 33,000 industrial robots were sold in the U.S. in 2017.
Hence, North America has a significantly high penetration of pharmaceutical robots, and this number is expected to grow in the near future due to rise in the number of pharmaceutical companies in the country. IFR also stated that North America is in the process of strengthening its pharmaceutical manufacturing units to compete with the global market through automation of its production facilities.
According to a 2017 news update by Vox Media, Inc., nearly 20.5% increase in pharmaceutical or life sciences robot unit shipments were observed in North America from 2012 to 2016. ABI Research predicted that there will be an approximately 300% increase in the unit sales of industrial robots in less than a decade in the U.S.
Reasons to subscribe to North America pharmaceutical robots market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America pharmaceutical robots market databook
-
Our clientele includes a mix of pharmaceutical robots market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America pharmaceutical robots market , including forecasts for subscribers. This continent databook contains high-level insights into North America pharmaceutical robots market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America pharmaceutical robots market size, by country, 2016-2030 (US$M)
North America Pharmaceutical Robots Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
